Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (401-410 of 421) with videos related to

Pageof 43
Sort By:
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent catheter-associated urinary tract infections in acute care hospitalsEvelyn Lo, Lindsay Nicolle, David Classen, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
A compendium of strategies to prevent healthcare-associated infections in acute care hospitalsDeborah S Yokoe, Leonard A Mermel, Deverick J Anderson, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent surgical site infections in acute care hospitalsDeverick J Anderson, Keith S Kaye, David Classen, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent central line-associated bloodstream infections in acute care hospitalsJonas Marschall, Leonard A Mermel, David Classen, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitalsDavid P Calfee, Cassandra D Salgado, David Classen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 2, 2026
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysisSaikumar Matcha, Gauri G Rao, Patrick O Hanafin, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2013
Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical CenterKayoko Hayakawa, Sureka Gattu, Dror Marchaim, et al.
NEJM Evidence|August 4, 2023
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant OrganismsKeith S Kaye, Dror Marchaim, Visanu Thamlikitkul, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control studyKayoko Hayakawa, Dror Marchaim, Mohan Palla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
Pageof 43

Showing results (401-410 of 421) with videos related to

Sort By:
Pageof 43
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent catheter-associated urinary tract infections in acute care hospitalsEvelyn Lo, Lindsay Nicolle, David Classen, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
A compendium of strategies to prevent healthcare-associated infections in acute care hospitalsDeborah S Yokoe, Leonard A Mermel, Deverick J Anderson, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent surgical site infections in acute care hospitalsDeverick J Anderson, Keith S Kaye, David Classen, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent central line-associated bloodstream infections in acute care hospitalsJonas Marschall, Leonard A Mermel, David Classen, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitalsDavid P Calfee, Cassandra D Salgado, David Classen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 2, 2026
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysisSaikumar Matcha, Gauri G Rao, Patrick O Hanafin, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2013
Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical CenterKayoko Hayakawa, Sureka Gattu, Dror Marchaim, et al.
NEJM Evidence|August 4, 2023
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant OrganismsKeith S Kaye, Dror Marchaim, Visanu Thamlikitkul, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control studyKayoko Hayakawa, Dror Marchaim, Mohan Palla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
Pageof 43